Home›People›Esra Roan
Esra Roan

Esra Roan

Chief Executive Officer and director at Corami Biotech. Also an executive officer and director at SOMAVAC Medical Solutions.

ExecutiveDirectorRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Apr 22, 2026·Suggest an edit

About Esra Roan

Esra Roan is a chief executive officer and director at Corami Biotech.

Form D filings also name Esra Roan as an executive officer and director at SOMAVAC Medical Solutions.

Esra Roan first appears on SEC filings in 2016.

Experience

This experience comes from Esra Roan's profile and from SEC filings. For roles taken from filings, the years are when the filings name Esra Roan in the role, so the role may have started earlier or lasted longer.

Corami Biotech Inc. Current
Executive officer
CEO / President / Board Member (2024 – Present)
2024 – Present · Memphis, TN
Corami develops a heart-targeted drug delivery system for companies developing cardiovascular therapies.
Innovare Current
Principal: Board | Investor | C-Suite Strategy Advisor
2023 – Present
SOMAVAC® Medical Solutions, Inc.
CEO / Co-Founder / President / Chairperson of the Board | Board Member (2023)
2016 – 2023
SOMAVAC Medical Solutions, Inc.
Executive officer and director
2016 – 2022 · Memphis, TN
The University of Memphis
Associate Professor, Biomedical Engineering
2007 – 2016
University of Cincinnati
Graduate Research Assistant | Teaching Assistant
2003 – 2007
3M Precision Optics
Product Development Engineer
2000 – 2003

Key Colleagues at Startups

The people Esra Roan works with at each company, as listed on that company's latest Form D.

Corami Biotech Inc. · Form D, Apr 22, 2026
Brian Walsh
Brian Walsh
Medical Technology Executive and director
NS
Rifat Pamukcu
Rifat Pamukcu
Chairperson of the Board
SOMAVAC Medical Solutions, Inc. · Form D/A, Nov 29, 2022
GC
Glen Coleman
Director
JB
Jan Bouten
Director
PR
Phil Ryan
Executive officer and director

Sources

  1. SECCorami Biotech Inc. Form D, filed Apr 22, 2026
  2. SECSOMAVAC Medical Solutions, Inc. Form D/A, filed Nov 29, 2022